Ron N. Van Schaik

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 269 publications

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

Journal: JCO precision oncology

Published: June 08, 2026

The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congress.

The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congress.

Journal: Pharmacogenomics

Published: April 02, 2026

Brief Report: Reducing Lorlatinib-Related Adverse Events by Establishing the Optimal Exposure-Toxicity Threshold in Patients With NSCLC.

Brief Report: Reducing Lorlatinib-Related Adverse Events by Establishing the Optimal Exposure-Toxicity Threshold in Patients With NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 10, 2026

Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.

Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 10, 2026

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Journal: Circulation. Cardiovascular interventions

Published: February 26, 2026

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Journal: Circulation. Cardiovascular interventions

Published: February 26, 2026

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.

Journal: Pharmacogenomics

Published: January 21, 2026

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.

Journal: Pharmacogenomics

Published: January 21, 2026

From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshop.

From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshop.

Journal: European journal of human genetics : EJHG

Published: January 08, 2026

Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy.

Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy.

Journal: Clinical and translational science

Published: November 18, 2025

Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.

Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.

Journal: The Lancet regional health. Europe

Published: November 14, 2025

Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.

Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 05, 2025

Showing 1-12 of 269

Last Updated: 09/26/2026